Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal composition for preventing and treating upper respiratory inflammation and preparation and application thereof

A composition and drug technology, which is applied in the direction of drug combination, medical preparations containing active ingredients, respiratory diseases, etc., can solve the problem that respiratory inflammation is extremely harmful to human health, and patients with allergen allergies are difficult to implement and treat The drug has no clear research and development direction, etc., to achieve the effect of active chemical properties, short drug effect, and isolation of allergens

Inactive Publication Date: 2015-04-29
章迅
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These surgical methods are traumatic to the human body and have a poor prognosis
[0008] 3. Desensitization treatment: Compared with the above three preventive treatment methods, desensitization therapy starts from the perspective of improving the body's own immunity, and is the most active from the perspective of medical cognition, but because this method only treats a single allergen It is effective, but the treatment cost is high, the cycle is long, the actual treatment effect is not exact, and it is very difficult to implement it for patients allergic to multiple allergens
[0013] Respiratory tract inflammation is extremely harmful to human health, and it has been widely valued by the world's medical community. Countries have invested a lot of research funding. However, due to the complexity of the mechanism of allergic reactions leading to the disease, it is difficult to form an accurate understanding, resulting in the use of therapeutic drugs. no clear development direction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] A kind of pharmaceutical composition, described pharmaceutical composition is made up of following percentage by weight 55% volatile oil, 40% peanut oil, 2% sweet leaf glucoside, 3% wheat germ oil, and described volatile oil is made of 35% peppermint oil, 22% % asarum oil, 22% tea tree oil, 13% lavender oil, 6.8% cinnamon oil, 0.6% camphor oil, 0.6% cedar oil.

[0056] The preparation method of above pharmaceutical composition, comprises the following steps,

[0057] Step 1: Mix peppermint oil, asarum oil, and tea tree oil according to the proportion at ≤25°C and place them for 24 hours;

[0058] Step 2: Mix the lavender oil and cinnamon oil evenly according to the proportion and place it for 12 hours;

[0059] Step 3: Mix the mixture of Step 1 and Step 2, stir evenly, add camphor oil and cedar oil, and seal it for later use;

[0060] Step 4: Heat up the vegetable oil to 70 degrees Celsius, add steviol glycoside, stir at a high speed, fully integrate the steviol glyco...

Embodiment 2

[0066] A kind of pharmaceutical composition for asthma and pharyngitis, described pharmaceutical composition is made up of following percentage by weight 40% volatile oil, 55% rapeseed oil and 2% sweet leaf glucoside, 3% wheat germ, described volatile oil is made of 40% peppermint oil, 23.7% asarum oil, 20% tea tree oil, 10% lavender oil, 5% cinnamon oil, 0.8% camphor oil, 0.5% cedar oil.

[0067] The preparation method of above pharmaceutical composition, comprises the following steps,

[0068] Step 1: Mix peppermint oil, asarum oil, and tea tree oil according to the proportion at ≤25°C and place them for 24 hours;

[0069] Step 2: Mix the lavender oil and cinnamon oil evenly according to the proportion and place it for 12 hours;

[0070] Step 3: Mix the mixture of Step 1 and Step 2, stir evenly, add camphor oil and cedar oil, and seal it for later use;

[0071] Step 4: Heat up the vegetable oil to 70 degrees Celsius, add steviol glycoside, stir at a high speed, fully integ...

Embodiment 3

[0076] A kind of medicinal composition for bronchitis, tracheitis, described medicinal composition is made up of following percentage by weight 65% volatile oil, 30% linseed oil and 2% sweet leaf glucoside, 3% wheat germ, described volatile oil Composed of 32.7% peppermint oil, 25% asarum oil, 23% tea tree oil, 12% lavender oil, 6% cinnamon oil, 0.5% camphor oil, 0.8% cedar oil.

[0077] The preparation method of above pharmaceutical composition, comprises the following steps,

[0078] Step 1: Mix peppermint oil, asarum oil, and tea tree oil according to the proportion at ≤25°C and place them for 24 hours;

[0079] Step 2: Mix the lavender oil and cinnamon oil evenly according to the proportion and place it for 12 hours;

[0080] Step 3: Mix the mixture of Step 1 and Step 2, stir evenly, add camphor oil and cedar oil, and seal it for later use;

[0081] Step 4: Heat up the vegetable oil to 70 degrees Celsius, add steviol glycoside, stir at a high speed, fully integrate the s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating upper respiratory track inflammation, in particular to a medicinal composition for preventing and treating upper respiratory tract inflammation and preparation and application thereof. The medicinal composition comprises the following components in percentage by weight: 40-85 percent of volatile oil, 10-55 percent of vegetable oil and 5-8 percent of an adjuvant, wherein the volatile oil comprises 30-40 percent of mint oil, 20-25 percent of asarum oil, 20-25 percent of tea tree oil, 10-15 percent of lavender oil, 5-8 percent of cinnamon oil, 0.5-0.8 percent of camphor oil and 0.5-0.8 percent of cedar oil. The medicinal composition can diffuse fast with respiratory airflow in a respiratory tract, and forms an oily thin film on the surface of respiratory mucosa and in the deep part of the respiratory tract to realize the multiple purposes of isolating sensitinogen, reducing water evaporation and releasing drugs. Aiming at the physiological characteristics of the respiratory tract, the medicinal composition particularly solves the contradiction between deep airways and administration difficulty, can enter and stay in the deep airways, meanwhile realizes protection and treatment for the respiratory mucosa, and ensures that respiratory diseases are not difficult to treat any more.

Description

technical field [0001] The invention relates to a medicine for treating upper respiratory tract inflammation, in particular to a pharmaceutical composition, preparation and application for preventing and treating upper respiratory tract inflammation. Background technique [0002] Ancient medicine believes that the respiratory system is "delicate", which means that the respiratory system is prone to disease, especially the upper respiratory tract will be inflamed due to extremely small pathogenic factors, and it is difficult to cure. Respiratory tract inflammation is mainly manifested as mucosal congestion, edema, ulcers and other lesions caused by allergies, so it is also called respiratory tract mucositis. According to the specific parts of the mucosal inflammation, they are also called: rhinitis, pharyngitis, sinusitis, trachea, bronchitis and so on. The main symptoms of upper respiratory tract inflammation are dryness, runny nose, blockage, pain, sneezing, coughing, ast...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/61A61P11/00A61K31/125
Inventor 章迅
Owner 章迅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products